Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001595 |
---|---|
Receipt number | R000001908 |
Scientific Title | Randomized phase II study comparing Gemcitabine versus TS-1 for advanced bile duct cancer |
Date of disclosure of the study information | 2008/12/22 |
Last modified on | 2019/04/08 13:00:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/12/22 10:04:11 | ||
2 | Update | 2009/12/28 19:06:13 | Recruitment status |
|
3 | Update | 2011/07/02 09:34:05 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2012/06/25 09:52:41 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2013/12/24 20:27:29 | Email |
|
6 | Update | 2017/05/16 19:10:32 | Organization Organization TEL Organization Organization TEL Organization Organization TEL Name of primary person or sponsor Institute Institute Organization Organization1 Tel1 |
|
7 | Update | 2019/04/08 13:00:45 | Recruitment status Date of IRB |